A Promising HIV Vaccine Shows Signs of Cross-Protective Benefits (1 of 2) (IMAGE)

American Association for the Advancement of Science (AAAS)

A Promising HIV Vaccine Shows Signs of Cross-Protective Benefits (1 of 2)

Caption

Professor Glenda Gray, CEO and President of the South African Medical Research Council, CoPI of the HIV Vaccine Trials Network. This material relates to a paper that appeared in the Sep. 18, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by G.E. Gray at University of the Witwatersrand in Johannesburg; South Africa; and colleagues was titled, "Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa."

Credit

Credit: ©South African Medical Research Council

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.